Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Hopes For User Fee Un-Sequestration Likely Hinge On Senate Appropriations Panel

Jun 14 2013

• By Cathy Dombrowski

Related Content

FDA’s 8.2% Solution: Sequestration Would Cut $319 Million

Sep 14 2012

FDA’s Sequestered User Fees From FY 2013 Likely Gone, But FY 2014 Fees Could Be Exempted

Jun 05 2013

Additional Topics

United States Legislation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window